piretanide (Compound)

Synonyms:piretanide, 55837-27-9, Tauliz, 4-phenoxy-3-pyrrolidin-1-yl-5-sulfamoylbenzoic acid, Eurelix, HOE 118, 4-phenoxy-3-(pyrrolidin-1-yl)-5-sulfamoylbenzoic acid, Tauliz-d4, Hoe-118, Benzoic acid, 3-(aminosulfonyl)-4-phenoxy-5-(1-pyrrolidinyl)-, S 73 4118, DQ6KK6GV93, 4-Phenoxy-3-(1-pyrrolidinyl)-5-sulfamoylbenzoic acid, DTXSID2023488, NCGC00016878-01, Arlix, CAS-55837-27-9, S-734118, DTXCID703488, S-73-4118, Piretanido [Spanish], Piretanido, Piretanidum, Piretanidum [INN-Latin], Piretanido [INN-Spanish], Arelix (TN), EINECS 259-852-9, UNII-DQ6KK6GV93, BRN 5633965, Piretanide [USAN:INN:BAN:JAN], Piretanide-[d4], S 734118, 3-(Aminosulfonyl)-4-phenoxy-5-(1-pyrrolidinyl)-benzoic acid, PIRETANIDE [MI], PIRETANIDE [INN], PIRETANIDE [JAN], Acide phenoxy-4-(1-pyrrolidinyl)-3-sulfamoyl-5 benzoique [French], Prestwick0_001047, Prestwick1_001047, Prestwick2_001047, Prestwick3_001047, PIRETANIDE [USAN], PIRETANIDE [MART.], PIRETANIDE [WHO-DD], SCHEMBL49473, BSPBio_000974, MLS002154123, Piretanide (JAN/USAN/INN), SPBio_002907, BPBio1_001072, CHEMBL349803, GTPL4742, CHEBI:32015, Piretanide for system suitability, Acide phenoxy-4-(1-pyrrolidinyl)-3-sulfamoyl-5 benzoique, PIRETANIDE [EP MONOGRAPH], HMS1571A16, HMS2098A16, HMS2230G15, HMS3372O22, HMS3715A16, Tox21_110661, AKOS015895445, Tox21_110661_1, CCG-221047, DB02925, NCGC00016878-02, NCGC00016878-04, MS-25753, SMR001233430, HY-119816, AB00514020, CS-0078068, FT-0673944, 2-Methyl-2-propylpropane-1,3-diyl dicarbamate, D01634, A924106, EN300-18568088, SR-01000838837, 4-phenoxy-3-(pyrrolidinyl)-5-sulfamoylbenzoic acid, Q3905617, SR-01000838837-2, W-105543, 3-(1-pyrrolidinyl)-4-phenoxy-5-sulphamylbenzoic acid, BRD-K87990216-001-03-7, 4-phenoxy-3-(1-pyrrolidinyl)-5-sulphamoylbenzoic acid, F2173-0688, 3-(aminosulfonyl)-4-(phenyloxy)-5-pyrrolidin-1-ylbenzoic acid

Pubchem:PUBCHEM:4849

Id:75ff78cd-2608-5161-b09a-37d0d5080a27

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View piretanide's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for piretanide.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with piretanide.

Results found

Linked to

	Label	Description
	BRD-K87990216-001-10-2 Substance (Entity type)	A Substance
	DCSTRUCT ID 02201 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02201; PubChem_CID:4849, FILE=drugcentral_drug_02201.json)
	piretanide (a0e3e284-4475-4b5b-b761-3905b4a105e7) Collection (Entity type)	Metadatata for piretanide
	piretanide positively regulates SLC4A4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	piretanide positively regulates TMEM176B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	piretanide positively regulates ID4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	piretanide positively regulates BEX1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	piretanide positively regulates CXCL14 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	piretanide positively regulates TUBB2B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	piretanide negatively regulates NXN Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS